Amrutanjan Approves Revised ESOP 2 Scheme

Amrutanjan Health Care board approved a revised second phase of its ESOP 2020 scheme on 8 May 2026.
The scheme grants 200,000 equity shares over 5 years with vesting linked to FY27-FY31 sales targets.
Grant price is set at ₹502 per share, a 10% discount to the NSE closing price of ₹558 on 7 May 2026.
The scheme will be implemented through an ESOP Trust managed by Surana & Surana.